<DOC>
	<DOCNO>NCT03039855</DOCNO>
	<brief_summary>To evaluate safety performance Neovasc Tiara Mitral Transcatheter Heart Valve Tiara Transapical Delivery System .</brief_summary>
	<brief_title>Tiaraâ„¢ Transcatheter Mitral Valve Replacement Study</brief_title>
	<detailed_description>The TIARA-II study international , multicenter , single-arm , prospective , safety performance clinical study .</detailed_description>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<criteria>Severe mitral regurgitation High surgical risk open mitral valve surgery Subject meet anatomical eligibility criterion Deemed frail objective frailty assessment Previous cardiac procedure : mitral valve replacement surgery cardiac transplant Unsuitable cardiac structure Clinically significant untreated Coronary Artery Disease ( CAD ) Subjects chronic dialysis Pregnant planning pregnancy within next 12 month Documented bleed coagulation disorder Active infection require antibiotic therapy Subjects life expectancy le 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Mitral</keyword>
	<keyword>Regurgitation</keyword>
	<keyword>Heart valve</keyword>
	<keyword>Transcatheter</keyword>
	<keyword>Transapical</keyword>
	<keyword>Functional</keyword>
	<keyword>Degenerative</keyword>
	<keyword>TMVR</keyword>
</DOC>